Found: 9
Select item for more details and to access through your institution.
Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritis.
- Published in:
- Rheumatology, 2022, v. 61, n. 8, p. 3257, doi. 10.1093/rheumatology/keab905
- By:
- Publication type:
- Article
Non-radiographic axial spondyloarthritis patients without initial evidence of inflammation may develop objective inflammation over time.
- Published in:
- Rheumatology, 2017, v. 56, n. 7, p. 1162, doi. 10.1093/rheumatology/kex081
- By:
- Publication type:
- Article
A3: Efficacy and Safety of Adalimumab in Pediatric Patients With Enthesitis Related Arthritis.
- Published in:
- Arthritis & Rheumatology, 2014, v. 66, p. S4, doi. 10.1002/art.38414
- By:
- Publication type:
- Article
Low Incidence of Inflammatory Bowel Disease Adverse Events in Adalimumab Clinical Trials Across Nine Different Diseases.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis-Related Arthritis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Patient outcomes in rheumatology, 2011: a review of measures. Measures of rheumatoid arthritis disease activity.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score With 28-Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score-II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5), Chronic Arthritis Systemic Index (CASI), Patient-Based Disease Activity Score With ESR (PDAS1) and Patient-Based Disease Activity Score Without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI-RA)
- Published in:
- Arthritis Care & Research, 2011, v. 63, p. S14, doi. 10.1002/acr.20621
- By:
- Publication type:
- Article
Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial.
- Published in:
- Arthritis Research & Therapy, 2018, v. 20, p. 1, doi. 10.1186/s13075-018-1556-5
- By:
- Publication type:
- Article
Upadacitinib pharmacokinetics and exposure‐response analyses of efficacy and safety in psoriatic arthritis patients – Analyses of phase III clinical trials.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 1, p. 267, doi. 10.1111/cts.13146
- By:
- Publication type:
- Article